{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:07:59Z","timestamp":1787317679190,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001840","name":"RANN\u00cdS","doi-asserted-by":"publisher","award":["142264"],"award-info":[{"award-number":["142264"]}],"id":[{"id":"10.13039\/501100001840","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001840","name":"RANN\u00cdS","doi-asserted-by":"publisher","award":["163947"],"award-info":[{"award-number":["163947"]}],"id":[{"id":"10.13039\/501100001840","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001840","name":"RANN\u00cdS","doi-asserted-by":"publisher","award":["186943"],"award-info":[{"award-number":["186943"]}],"id":[{"id":"10.13039\/501100001840","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011103","name":"Rann\u00eds","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011103","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005415","name":"H\u00e1sk\u00f3li \u00cdslands","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005415","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.pupt.2025.102363","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T19:31:47Z","timestamp":1748979107000},"page":"102363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["A novel macrolide, EP395, with reduced antibacterial activity and an enhancing effect on respiratory epithelial barrier"],"prefix":"10.1016","volume":"90","author":[{"given":"Thorarinn","family":"Gudjonsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon Petur","family":"Joelsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ari Jon","family":"Arason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arni","family":"Asbjarnarson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fridrik Runar","family":"Gardarsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Teodorovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saevar","family":"Ingthorsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snaevar","family":"Sigurdsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryndis","family":"Valdimarsdottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael John","family":"Parnham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clive","family":"Page","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0757-1936","authenticated-orcid":false,"given":"Jennifer Ann","family":"Kricker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.pupt.2025.102363_bib1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jaci.2021.11.010","article-title":"The epithelial barrier hypothesis proposes a comprehensive understanding of the origins of allergic and other chronic noncommunicable diseases","volume":"149","author":"Akdis","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.pupt.2025.102363_bib2","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2017.1367458","article-title":"Airway epithelial barrier dysfunction in the pathogenesis and prognosis of respiratory tract diseases in childhood and adulthood","volume":"5","author":"Yuksel","year":"2017","journal-title":"Tissue Barriers"},{"issue":"2","key":"10.1016\/j.pupt.2025.102363_bib3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1165\/rcmb.2017-0200TR","article-title":"Airway epithelial barrier dysfunction in chronic obstructive pulmonary disease: role of cigarette smoke exposure","volume":"58","author":"Aghapour","year":"2018","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.pupt.2025.102363_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.691227","article-title":"Epithelial barrier dysfunction in chronic respiratory diseases","volume":"12","author":"Carlier","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.pupt.2025.102363_bib5","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3389\/fimmu.2020.00761","article-title":"More than just a barrier: the Immune functions of the airway epithelium in asthma pathogenesis","volume":"11","author":"Frey","year":"2020","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.pupt.2025.102363_bib6","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1124\/pharmrev.121.000300","article-title":"Nonantimicrobial actions of macrolides: overview and perspectives for future development","volume":"73","author":"Kricker","year":"2021","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.pupt.2025.102363_bib7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/bs.apha.2023.03.002","article-title":"Prospects for macrolide therapy of asthma and COPD","volume":"98","author":"Parnham","year":"2023","journal-title":"Adv. Pharmacol."},{"issue":"6","key":"10.1016\/j.pupt.2025.102363_bib8","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2213-2600(20)30080-1","article-title":"Immunomodulation by macrolides: therapeutic potential for critical care","volume":"8","author":"Reijnders","year":"2020","journal-title":"Lancet Respir. Med."},{"issue":"8","key":"10.1016\/j.pupt.2025.102363_bib9","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa1104623","article-title":"Azithromycin for prevention of exacerbations of COPD","volume":"365","author":"Albert","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.pupt.2025.102363_bib10","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00056-2019","article-title":"Efficacy of azithromycin in severe asthma from the AMAZES randomised trial","volume":"5","author":"Gibson","year":"2019","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.pupt.2025.102363_bib11","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.archoralbio.2015.11.015","article-title":"Azithromycin recovers reductions in barrier function in human gingival epithelial cells stimulated with tumor necrosis factor-alpha","volume":"62","author":"Miyagawa","year":"2016","journal-title":"Arch. Oral Biol."},{"issue":"18","key":"10.1016\/j.pupt.2025.102363_bib12","article-title":"The differential effects of azithromycin on the airway epithelium in vitro and in vivo","volume":"4","author":"Slater","year":"2016","journal-title":"Phys. Rep."},{"issue":"1","key":"10.1016\/j.pupt.2025.102363_bib13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12931-023-02375-9","article-title":"Azithromycin ameliorated cigarette smoke-induced airway epithelial barrier dysfunction by activating Nrf2\/GCL\/GSH signaling pathway","volume":"24","author":"Song","year":"2023","journal-title":"Respir. Res."},{"issue":"5","key":"10.1016\/j.pupt.2025.102363_bib14","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1128\/AAC.50.5.1805-1812.2006","article-title":"Novel effects of azithromycin on tight junction proteins in human airway epithelia","volume":"50","author":"Asgrimsson","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.pupt.2025.102363_bib15","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1165\/rcmb.2008-0357OC","article-title":"Azithromycin maintains airway epithelial integrity during Pseudomonas aeruginosa infection","volume":"42","author":"Halldorsson","year":"2010","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.pupt.2025.102363_bib16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12931-019-1101-3","article-title":"Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia","volume":"20","author":"Arason","year":"2019","journal-title":"Respir. Res."},{"issue":"5","key":"10.1016\/j.pupt.2025.102363_bib17","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/00325481.2017.1285677","article-title":"Immunomodulatory indications of azithromycin in respiratory disease: a concise review for the clinician","volume":"129","author":"Cramer","year":"2017","journal-title":"Postgrad. Med. J."},{"issue":"3","key":"10.1016\/j.pupt.2025.102363_bib18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/1753465816682677","article-title":"Macrolides: a promising pharmacologic therapy for chronic obstructive pulmonary disease","volume":"11","author":"Qiu","year":"2017","journal-title":"Ther. Adv. Respir. Dis."},{"issue":"2","key":"10.1016\/j.pupt.2025.102363_bib19","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1183\/09031936.00208011","article-title":"Macrolide effects on the prevention of COPD exacerbations","volume":"40","author":"Yamaya","year":"2012","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.pupt.2025.102363_bib20","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1128\/AAC.02011-12","article-title":"Blood, tissue, and intracellular concentrations of azithromycin during and after end of therapy","volume":"57","author":"Matzneller","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.pupt.2025.102363_bib21","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.pharmthera.2014.03.003","article-title":"Azithromycin: mechanisms of action and their relevance for clinical applications","volume":"143","author":"Parnham","year":"2014","journal-title":"Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.pupt.2025.102363_bib22","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0014-2999(02)02042-3","article-title":"Azithromycin modulates neutrophil function and circulating inflammatory mediators in healthy human subjects","volume":"450","author":"Culic","year":"2002","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.pupt.2025.102363_bib23","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.4049\/jimmunol.1801228","article-title":"Azithromycin polarizes macrophages to an M2 phenotype via inhibition of the STAT1 and NF-\u03baB signaling pathways","volume":"203","author":"Haydar","year":"2019","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.pupt.2025.102363_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105609","article-title":"The effect of azithromycin in adults with stable neutrophilic COPD: a double blind randomised, placebo controlled trial","volume":"9","author":"Simpson","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.pupt.2025.102363_bib26","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4269\/ajtmh.23-0651","article-title":"Gut microbiome diversity and antimicrobial resistance after a single dose of oral azithromycin in children: a randomized placebo-controlled trial","volume":"110","author":"Doan","year":"2024","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"6","key":"10.1016\/j.pupt.2025.102363_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107384","article-title":"A novel 12-membered ring non-antibiotic macrolide EM982 attenuates cytokine production by inhibiting IKKbeta and IkappaBalpha phosphorylation","volume":"300","author":"Saito","year":"2024","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.pupt.2025.102363_bib28","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/ja.2012.51","article-title":"Novel 12-membered non-antibiotic macrolides, EM900 series with anti-inflammatory and\/or immunomodulatory activity; synthesis, structure-activity relationships and in vivo study","volume":"65","author":"Sugawara","year":"2012","journal-title":"J. Antibiot. (Tokyo)"},{"issue":"11","key":"10.1016\/j.pupt.2025.102363_bib29","doi-asserted-by":"crossref","first-page":"L746","DOI":"10.1152\/ajplung.00292.2012","article-title":"Nonantibiotic macrolides prevent human neutrophil elastase-induced mucus stasis and airway surface liquid volume depletion","volume":"304","author":"Tarran","year":"2013","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"8\u20139","key":"10.1016\/j.pupt.2025.102363_bib30","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11626-007-9050-4","article-title":"Differentiation potential of a basal epithelial cell line established from human bronchial explant","volume":"43","author":"Halldorsson","year":"2007","journal-title":"In Vitro Cell. Dev. Biol. Anim."},{"issue":"4","key":"10.1016\/j.pupt.2025.102363_bib31","first-page":"634","article-title":"Innovative in vitro method to study ventilator induced lung injury","volume":"36","author":"Joelsson","year":"2019","journal-title":"ALTEX"},{"issue":"5","key":"10.1016\/j.pupt.2025.102363_bib32","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nbt.3519","article-title":"Near-optimal probabilistic RNA-seq quantification","volume":"34","author":"Bray","year":"2016","journal-title":"Nat. Biotechnol."},{"issue":"7","key":"10.1016\/j.pupt.2025.102363_bib33","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/nmeth.4324","article-title":"Differential analysis of RNA-seq incorporating quantification uncertainty","volume":"14","author":"Pimentel","year":"2017","journal-title":"Nat. Methods"},{"issue":"3","key":"10.1016\/j.pupt.2025.102363_bib34","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng1180","article-title":"PGC-1\u03b1-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes","volume":"34","author":"Mootha","year":"2003","journal-title":"Nat. Genet."},{"issue":"43","key":"10.1016\/j.pupt.2025.102363_bib35","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.pupt.2025.102363_bib36","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s12931-020-01489-8","article-title":"Azithromycin ameliorates sulfur dioxide-induced airway epithelial damage and inflammatory responses","volume":"21","author":"Joelsson","year":"2020","journal-title":"Respir. Res."},{"issue":"4","key":"10.1016\/j.pupt.2025.102363_bib37","first-page":"229","article-title":"[Effect of sulfuric acid vapors on the respiratory system]","volume":"36","author":"Pawelek-Krombholz","year":"1985","journal-title":"Med. Pr."},{"key":"10.1016\/j.pupt.2025.102363_bib38","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-020-01489-8","article-title":"Azithromycin ameliorates sulfur dioxide-induced airway epithelial damage and inflammatory response","author":"Joelsson","year":"2020","journal-title":"Respir. Res."},{"issue":"20","key":"10.1016\/j.pupt.2025.102363_bib39","doi-asserted-by":"crossref","first-page":"10779","DOI":"10.1073\/pnas.93.20.10779","article-title":"The junction-associated protein, zonula occludens-1, localizes to the nucleus before the maturation and during the remodeling of cell-cell contacts","volume":"93","author":"Gottardi","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.pupt.2025.102363_bib40","first-page":"545","article-title":"Azithromycin has lung barrier protective effects in a cell model mimicking ventilator-induced lung injury","volume":"37","author":"Joelsson","year":"2020","journal-title":"ALTEX"},{"issue":"10","key":"10.1016\/j.pupt.2025.102363_bib41","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.tcb.2020.08.004","article-title":"Tight junction structure and function revisited","volume":"30","author":"Otani","year":"2020","journal-title":"Trends Cell Biol."},{"issue":"7","key":"10.1016\/j.pupt.2025.102363_bib42","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1083\/jcb.201711042","article-title":"Adherens junctions influence tight junction formation via changes in membrane lipid composition","volume":"217","author":"Shigetomi","year":"2018","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.pupt.2025.102363_bib43","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.chemphyslip.2018.09.017","article-title":"State of the art in Stratum Corneum research: the biophysical properties of ceramides","volume":"216","author":"Schmitt","year":"2018","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.pupt.2025.102363_bib44","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/5954034","article-title":"Lipids and the permeability and antimicrobial barriers of the skin","volume":"2018","author":"Wertz","year":"2018","journal-title":"J. Lipids"},{"issue":"12","key":"10.1016\/j.pupt.2025.102363_bib45","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/labinvest.2015.114","article-title":"Basal cells of the human airways acquire mesenchymal traits in idiopathic pulmonary fibrosis and in culture","volume":"95","author":"Jonsdottir","year":"2015","journal-title":"Lab. Invest."},{"key":"10.1016\/j.pupt.2025.102363_bib46","series-title":"Inhibition Of Neutrophilic Inflammation by Targeting the Airway Epithelial Barrier with EP395 ERS Congress 2022","author":"Kricker","year":"2022"},{"key":"10.1016\/j.pupt.2025.102363_bib47","series-title":"In Vivo Inflammation Resolving Effect of EP395","author":"Riffo-Vasquez","year":"2023"}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553925000203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553925000203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T17:40:26Z","timestamp":1762364426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553925000203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":46,"alternative-id":["S1094553925000203"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2025.102363","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel macrolide, EP395, with reduced antibacterial activity and an enhancing effect on respiratory epithelial barrier","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2025.102363","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102363"}}